Entero Healthcare Solutions Schedules Board Meeting for Q2 Results on 4th Nov'26
Entero Healthcare Solutions Ltd 路 Intimation 路 04 Nov 2026, 5:30 am
Entero Healthcare Solutions Schedules Board Meeting for Q2 Results on 4th Nov'26 Entero Healthcare Solutions Limited has scheduled a Board of Directors meeting on 4th Nov'26 to consider, approve, and record its unaudited standalone and consolidated financial results, along with the limited review report, for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed for designated persons and their immediate relatives from 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Entero Healthcare Solutions Ltd
- Transcript of Earnings Call / Conference Call 路 13 Nov 2026
- Recording of Earnings Call/ Conference Call on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 3P India Equity Fund 路 05 Nov 2026
- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 路 05 Nov 2026
- Investor Presentation on Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
- Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 49712 Options. 路 05 Nov 2026
- Grant of fresh 49,712 (Forty-Nine Thousand Seven Hundred Twelve) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'. 路 05 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 05 Nov 2026
